Skip to main content

Advertisement

Log in

Preoperative chemotherapy unmasks underlying Barrett’s mucosa in patients with adenocarcinoma of the distal esophagus

  • Original Articles
  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Background

Intestinal metaplasia of the distal esophagus frequently cannot be detected in patients with esophageal adenocarcinoma. It has therefore been questioned whether Barrett’s esophagus is the primary precursor lesion of such lesions. We hypothesized that the underlying Barrett’s mucosa may be masked by tumor overgrowth in the majority of these patients.

Methods

The pretherapeutic endoscopy and biopsy records of 79 patients with locally advanced esophageal adenocarcinoma who had undergone preoperative chemotherapy were reviewed and compared to findings on restaging endoscopy/biopsy and subsequent resection and histopathologic analysis of the resected specimen.

Results

Pretherapeutic endoscopy and biopsy showed associated Barrett’s esophagus in 59/79 patients, whereas there was no evidence of associated intestinal metaplasia in 20/79 patients on extensive biopsies. Following neoadjuvant chemotherapy, Barrett’s mucosa was unmasked and later documented by biopsy or histopathologic assessment of the resected specimen in 18 of the latter 20 patients. This resulted in an overall association of Barrett’s mucosa with adenocarcinoma in the distal esophagus of 97.4%

Conclusion

Underlying Barrett’s mucosa is frequently masked by tumor overgrowth in patients with locally advanced adenocarcinoma of the distal esophagus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Blot WJ, Devesa SS, Kneller RW, fraumeni JF (1991) Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265: 1287–1289

    Article  CAS  PubMed  Google Scholar 

  2. Cameron AJ, Lomboy CT, Pera M., Carpenter HA (1995) Adenocarcinoma of the esophagogastric junction and Barrett’s esophagus. Gastroenterology 109: 1541–1546

    Article  CAS  PubMed  Google Scholar 

  3. Cameron AJ, Ou BJ, Payne WS (1985) The incidence of adenocarcinoma in cloumnar-lined (Barrett’s) esophagus. N Engl J Med 313: 857–859

    Article  CAS  PubMed  Google Scholar 

  4. Devesa SS, Blot WJ, Fraumeni JF (1998) Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83: 2049–2053

    Article  CAS  PubMed  Google Scholar 

  5. Hamilton SR, Smith RRL, Cameron JL (1988) Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol 19: 942–948

    Article  CAS  PubMed  Google Scholar 

  6. Johansson J, Johnsson F, Walter B, Willen R, tael von Hostein C, Zilling T (1996) Adenocarcinoma of the distal esophagus with and without Barrett esophagus. Arch Surg 131: 708–713

    Article  CAS  PubMed  Google Scholar 

  7. Landis SH, Murray T, Bolden S, Wingo PA (1999) Cancer statistics. CA Cancer J Clin. 49: 8–31

    Article  CAS  PubMed  Google Scholar 

  8. Mendes de Almeida JC, Chaves P, Pereira D (1997) Is Barrett’s esophagus the precursor of most adenocarcinomas of the esophagus and cardia? a biochemical study. Ann Surg 226: 725–735

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Menke-Pluymers MBE, Schoute NW, Mulder AH, Hop WCJ, van Blankenstein M, Tilanus HW (1992) Outcome of surgical treatment of adenocarcinoma in Barrett esophagus. Gut 33: 1454–1458

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Peters JH, Clark GW, Ireland AP (1994) Outcome of adenocarcinoma arising in Barrett’s esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 108: 813–822

    CAS  PubMed  Google Scholar 

  11. Provenzale D, Kemp JA, Arora S (1994) A guide for surveillance of patients with Barrett’s esophagus. Am J Gastroenterol 89: 670–680

    CAS  PubMed  Google Scholar 

  12. Sabel MS, Pastore K, Toon H, Smith JL (2000) Adenocarcinoma of the esophagus with and without Barrett mucosa. Arch Surg 135: 831–835

    Article  CAS  PubMed  Google Scholar 

  13. Siewert JR, Feith M, Werner M, Stein HJ (2000) Adenocarcinoma of the esophagogastric junction. Ann Surg 232: 353–361

    Article  Google Scholar 

  14. Siewert JR, Stein HJ (1998) Classification of carcinoma of the esophago-gastric junction. Br J Surg 85: 1457–1459

    Article  CAS  PubMed  Google Scholar 

  15. Spechler SJ, Goyal RK, (1986) Barrett’s esophagus. N Engl J Med 315: 362–371

    Article  CAS  PubMed  Google Scholar 

  16. Theisen J, Oberg S (1999) Esophageal adenocarcinoma: is Barrett’s truly to blame? Am J Gastroenterol 94: 1103–1104

    CAS  PubMed  Google Scholar 

  17. Winters C, Spurling TJ, Chobanian SJ (1987) Barrett esophagus: a prevalent occult complication of gastroesophageal reflux disease. Gastroenterology 92: 118–124

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Presented at the annual meeting of the Society of American Gastro-intestinal Surgeons (SAGES), St. Louis, Missouri, USA, 18–21 April 2001

Rights and permissions

Reprints and permissions

About this article

Cite this article

Theisen, J., Stein, H.J., Dittler, H.J. et al. Preoperative chemotherapy unmasks underlying Barrett’s mucosa in patients with adenocarcinoma of the distal esophagus. Surg Endosc 16, 671–673 (2002). https://doi.org/10.1007/s00464-001-8307-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-001-8307-3

Key words

Navigation